Senior insider sale
MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$48.11M
89.78K shares
What this filing means
TAUB REBECCA plans to sell 89.78K shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $48.11M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/26/2026ACC: 0001628280-26-003442
Director
Since Mar 2026
89.78K
Shares to sell
$48.11M
Approx. market value
647.00
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Grant
Vesting of Restricted Stock Units
1/23/2026
647.00Total acquired647.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/23/2026 | Restricted Stock Unit Grant Vesting of Restricted Stock Units | 647.00 | — |
| Total | 647.00 | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
2.24K
Market value
$1.10M
1/20/2026
—Completed
Units to sell
24.80K
Market value
$12.96M
1/9/2026
—Completed
Units to sell
18.65K
Market value
$9.75M
1/9/2026
—Completed
Units to sell
18.65K
Market value
$10.30M
12/10/2025
—Completed
Units to sell
24.80K
Market value
$13.69M
12/10/2025
Planned — Approximate Date
Nasdaq Stock MarketPlanned
Units to sell
647.00
Market value
$310.9K
1/26/2026
Total
Units
89.78K
Value
$48.11M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/20/2026 | 2.24K | $1.10M | — | Completed |
1/9/2026 | 24.80K | $12.96M | — | Completed |
1/9/2026 | 18.65K | $9.75M | — | Completed |
12/10/2025 | 18.65K | $10.30M | — | Completed |
12/10/2025 | 24.80K | $13.69M | — | Completed |
| Planned — Approximate Date | ||||
1/26/2026 | 647.00 | $310.9K | Nasdaq Stock Market | Planned |
| Total | 89.78K | $48.11M | ||